USD 0.29
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -57.95 Million DKK | 22.22% |
2022 | -77.81 Million DKK | -26.13% |
2021 | -58.59 Million DKK | 5.58% |
2020 | -62.06 Million DKK | 12.67% |
2019 | -71.06 Million DKK | -73.17% |
2018 | -41.03 Million DKK | -12.34% |
2017 | -36.52 Million DKK | -49.22% |
2016 | -24.48 Million DKK | -96.86% |
2015 | -12.43 Million DKK | 16.05% |
2014 | -14.81 Million DKK | 26.28% |
2013 | -20.09 Million DKK | -44.09% |
2012 | -13.94 Million DKK | -9.08% |
2011 | -12.87 Million DKK | 1.62% |
2010 | -12.99 Million DKK | 16.43% |
2009 | -15.54 Million DKK | -13.81% |
2008 | -14.23 Million DKK | -7.84% |
2007 | -12.66 Million DKK | -177.44% |
2006 | -12.95 Million DKK | 5.07% |
2005 | 15.57 Million DKK | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -17.29 Million DKK | -22.21% |
2024 Q1 | -14.08 Million DKK | -17.9% |
2023 Q2 | -17.17 Million DKK | -5.76% |
2023 Q4 | -14.26 Million DKK | -65.98% |
2023 Q3 | -8.59 Million DKK | 49.97% |
2023 Q1 | -16.24 Million DKK | 33.21% |
2023 FY | - DKK | 22.22% |
2022 Q4 | -24.31 Million DKK | -41.78% |
2022 FY | - DKK | -26.13% |
2022 Q1 | -16.97 Million DKK | -3.12% |
2022 Q2 | -18.05 Million DKK | -6.4% |
2022 Q3 | -17.15 Million DKK | 5.02% |
2021 Q4 | -16.45 Million DKK | -32.16% |
2021 FY | - DKK | 5.58% |
2021 Q1 | -15.8 Million DKK | -11.68% |
2021 Q2 | -13.47 Million DKK | 14.74% |
2021 Q3 | -12.45 Million DKK | 7.57% |
2020 Q3 | -16.6 Million DKK | -6.49% |
2020 Q1 | -15.58 Million DKK | 0.23% |
2020 FY | - DKK | 12.67% |
2020 Q2 | -15.58 Million DKK | -0.04% |
2020 Q4 | -14.15 Million DKK | 14.76% |
2019 Q2 | -15.79 Million DKK | 3.92% |
2019 Q4 | -15.61 Million DKK | 32.74% |
2019 Q3 | -23.21 Million DKK | -47.03% |
2019 FY | - DKK | -73.17% |
2019 Q1 | -16.43 Million DKK | -122.14% |
2018 Q4 | -7.39 Million DKK | 35.05% |
2018 FY | - DKK | -12.34% |
2018 Q1 | -12.42 Million DKK | -44.16% |
2018 Q2 | -9.81 Million DKK | 20.99% |
2018 Q3 | -11.39 Million DKK | -16.01% |
2017 Q1 | -9.13 Million DKK | -103.57% |
2017 Q4 | -8.62 Million DKK | 18.22% |
2017 Q3 | -10.54 Million DKK | -27.99% |
2017 FY | - DKK | -49.22% |
2017 Q2 | -8.23 Million DKK | 9.86% |
2016 Q4 | -4.48 Million DKK | 36.13% |
2016 FY | - DKK | -96.86% |
2016 Q1 | -5.35 Million DKK | -158.29% |
2016 Q2 | -7.6 Million DKK | -42.04% |
2016 Q3 | -7.02 Million DKK | 7.65% |
2015 Q1 | -4.35 Million DKK | -65.6% |
2015 Q3 | -2.03 Million DKK | 48.69% |
2015 Q4 | -2.07 Million DKK | -1.87% |
2015 Q2 | -3.96 Million DKK | 8.93% |
2015 FY | - DKK | 16.05% |
2014 Q1 | -3.57 Million DKK | 30.24% |
2014 FY | - DKK | 26.28% |
2014 Q3 | -2.99 Million DKK | 46.55% |
2014 Q4 | -2.63 Million DKK | 12.24% |
2014 Q2 | -5.6 Million DKK | -56.94% |
2013 Q1 | -5.06 Million DKK | 77.04% |
2013 FY | - DKK | -44.09% |
2013 Q3 | -5.42 Million DKK | -21.07% |
2013 Q4 | -5.12 Million DKK | 5.57% |
2013 Q2 | -4.48 Million DKK | 11.48% |
2012 Q4 | -22.04 Million DKK | -869.83% |
2012 Q2 | -3.54 Million DKK | 2.45% |
2012 Q1 | -3.63 Million DKK | -1.85% |
2012 Q3 | 2.86 Million DKK | 180.84% |
2012 FY | - DKK | -9.08% |
2011 Q1 | -1.22 Million DKK | 66.33% |
2011 Q3 | -1.58 Million DKK | 68.27% |
2011 Q4 | -3.56 Million DKK | -125.7% |
2011 FY | - DKK | 1.62% |
2011 Q2 | -4.98 Million DKK | -305.87% |
2010 Q2 | -2.89 Million DKK | 14.4% |
2010 Q4 | -3.64 Million DKK | -18.62% |
2010 Q3 | -3.07 Million DKK | -6.15% |
2010 FY | - DKK | 16.43% |
2010 Q1 | -3.38 Million DKK | 9.98% |
2009 Q3 | -3.44 Million DKK | 27.79% |
2009 Q1 | -3.57 Million DKK | 0.0% |
2009 FY | - DKK | -13.81% |
2009 Q4 | -3.75 Million DKK | -9.03% |
2009 Q2 | -4.77 Million DKK | -33.42% |
2008 FY | - DKK | -7.84% |
2007 FY | - DKK | -177.44% |
2006 FY | - DKK | 5.07% |
2005 FY | - DKK | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
American Bio Medica Corporation | -1.16 Million USD | -4883.491% |
Arrayit Corporation | -3.07 Million USD | -1783.285% |
Atlantic International Corp. | -5.38 Million USD | -975.375% |
Biocept, Inc. | -30.24 Million USD | -91.654% |
Bioqual, Inc. | 3.03 Million USD | 2011.392% |
CardioGenics Holdings Inc | -757.37 Thousand USD | -7552.484% |
DermTech, Inc. | -97.89 Million USD | 40.795% |
Global WholeHealth Partners Corporation | - USD | Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 2.91 Billion USD | 101.989% |
HTG Molecular Diagnostics, Inc. | -20.24 Million USD | -186.319% |
iMD Companies, Inc. | -154.65 Thousand USD | -37374.702% |
IDenta Corp. | 71.58 Thousand USD | 81061.627% |
Interpace Biosciences, Inc. | 3.83 Million USD | 1610.503% |
Integrative Health Technologies, Inc. | 38.69 Thousand USD | 149900.982% |
InVitro International | 6680.00 USD | 867734.731% |
Lumos Diagnostics Holdings Limited | -5.43 Million USD | -966.188% |
Many Bright Ideas Technologies Inc. | -12.13 Thousand USD | -477549.58% |
Medical Imaging Corp. | -896.74 Thousand USD | -6363.174% |
NovelStem International Corp. | -3.78 Million USD | -1430.932% |
Optigenex Inc. | -1.18 Million USD | -4783.865% |
PharmChem, Inc. | 1.05 Million USD | 5599.853% |
Proteome Sciences plc | -1.13 Million USD | -4997.449% |
Response Genetics, Inc | -19.66 Million USD | -194.712% |
Rennova Health, Inc. | -234.81 Thousand USD | -24582.41% |
RushNet, Inc. | -614.85 Thousand USD | -9326.333% |
ScreenPro Security Inc. | -3.43 Million USD | -1587.333% |
Stella Diagnostics Inc. | -5.7 Million USD | -915.483% |
StageZero Life Sciences Ltd. | -10.27 Million USD | -464.335% |
Todos Medical Ltd. | -9.39 Million USD | -516.968% |